He is a recognized innovator with a particular interest in ‘disruptive’ technologies designed to improve patient care that have included devices, diagnostics and drugs. Some of his work has already changed practice, making some of the ‘most important contributions’ to the development and implementation of subcutaneous defibrillators. His clinical research focus is currently on both high-resolution charge density mapping of cardiac activation and risk prediction of ventricular fibrillation.